172 related articles for article (PubMed ID: 29658793)
1. Growing BI-RADS category 3 lesions on follow-up breast ultrasound: malignancy rates and worrisome features.
Ha SM; Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
Br J Radiol; 2018 Jul; 91(1087):20170787. PubMed ID: 29658793
[TBL] [Abstract][Full Text] [Related]
2. Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.
Chae EY; Cha JH; Shin HJ; Choi WJ; Kim HH
AJR Am J Roentgenol; 2016 Mar; 206(3):666-72. PubMed ID: 26901026
[TBL] [Abstract][Full Text] [Related]
3. Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.
Barr RG; Zhang Z; Cormack JB; Mendelson EB; Berg WA
Radiology; 2013 Dec; 269(3):701-12. PubMed ID: 23962417
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of classification of breast ultrasound findings based on criteria used for BI-RADS.
Heinig J; Witteler R; Schmitz R; Kiesel L; Steinhard J
Ultrasound Obstet Gynecol; 2008 Sep; 32(4):573-8. PubMed ID: 18421795
[TBL] [Abstract][Full Text] [Related]
5. Breast ultrasound diagnostic performance and outcomes for mass lesions using Breast Imaging Reporting and Data System category 0 mammogram.
Zanello PA; Robim AF; Oliveira TM; Elias Junior J; Andrade JM; Monteiro CR; Sarmento Filho JM; Carrara HH; Muglia VF
Clinics (Sao Paulo); 2011; 66(3):443-8. PubMed ID: 21552670
[TBL] [Abstract][Full Text] [Related]
6. Risk of malignancy in palpable solid breast masses considered probably benign or low suspicion: implications for management.
Giess CS; Smeglin LZ; Meyer JE; Ritner JA; Birdwell RL
J Ultrasound Med; 2012 Dec; 31(12):1943-9. PubMed ID: 23197547
[TBL] [Abstract][Full Text] [Related]
7. A Single-Center Audit of BI-RADS 3 Assessment Category Utilization in Mammography and Breast Ultrasound.
Common J; Abdullah P; Alabousi A
Can Assoc Radiol J; 2023 Feb; 74(1):69-77. PubMed ID: 36041944
[No Abstract] [Full Text] [Related]
8. BI-RADS Category 5 Assessments at Diagnostic Breast Imaging:Outcomes Analysis Based on Lesion Descriptors.
Yao MM; Joe BN; Sickles EA; Lee CS
Acad Radiol; 2019 Aug; 26(8):1048-1052. PubMed ID: 30195413
[TBL] [Abstract][Full Text] [Related]
9. Can Ultrasound Elastography Help Better Manage Mammographic BI-RADS Category 4 Breast Lesions?
Gu Y; Tian J; Ran H; Ren W; Chang C; Yuan J; Kang C; Deng Y; Wang H; Luo B; Guo S; Zhou Q; Xue E; Zhan W; Zhou Q; Li J; Zhou P; Zhang C; Chen M; Gu Y; Xu J; Chen W; Zhang Y; Li J; Wang H; Jiang Y
Clin Breast Cancer; 2022 Jun; 22(4):e407-e416. PubMed ID: 34815174
[TBL] [Abstract][Full Text] [Related]
10. Cancer Yield and Patterns of Follow-up for BI-RADS Category 3 after Screening Mammography Recall in the National Mammography Database.
Berg WA; Berg JM; Sickles EA; Burnside ES; Zuley ML; Rosenberg RD; Lee CS
Radiology; 2020 Jul; 296(1):32-41. PubMed ID: 32427557
[TBL] [Abstract][Full Text] [Related]
11. Detection and diagnosis of automated breast ultrasound in patients with BI-RADS category 4 microcalcifications: a retrospective study.
Yu LF; Dai CC; Zhu LX; Xu XJ; Yan HJ; Jiang CX; Bao LY
BMC Med Imaging; 2024 May; 24(1):126. PubMed ID: 38807064
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic value of breast ultrasound in mammography BI-RADS 0 and clinically indeterminate or suspicious of malignancy breast lesions.
Dobrosavljević A; Rakić S; Nikoli B; Raznatović SJ; Dikić SD; Milosević Z; Jurisić A; Skrobić M
Vojnosanit Pregl; 2016 Mar; 73(3):239-45. PubMed ID: 27295907
[TBL] [Abstract][Full Text] [Related]
13. The Utility of the Fifth Edition of the BI-RADS Ultrasound Lexicon in Category 4 Breast Lesions: A Prospective Multicenter Study in China.
Gu Y; Tian JW; Ran HT; Ren WD; Chang C; Yuan JJ; Kang CS; Deng YB; Wang H; Luo BM; Guo SL; Zhou Q; Xue ES; Zhan WW; Zhou Q; Li J; Zhou P; Zhang CQ; Chen M; Gu Y; Xu JF; Chen W; Zhang YH; Wang HQ; Li JC; Wang HY; Jiang YX
Acad Radiol; 2022 Jan; 29 Suppl 1():S26-S34. PubMed ID: 32768352
[TBL] [Abstract][Full Text] [Related]
14. Outcome of Imaging and Biopsy of BI-RADS Category 3 Lesions: Follow-Up Compliance, Biopsy, and Malignancy Rates in a Large Patient Cohort.
Polat DS; Merchant K; Hayes J; Omar L; Compton L; Dogan BE
J Ultrasound Med; 2023 Jun; 42(6):1285-1296. PubMed ID: 36445017
[TBL] [Abstract][Full Text] [Related]
15. Downgrading and Upgrading Gray-Scale Ultrasound BI-RADS Categories of Benign and Malignant Masses With Optoacoustics: A Pilot Study.
Neuschler EI; Lavin PT; Tucker FL; Barke LD; Bertrand ML; Böhm-Vélez M; Destounis S; Dogan BE; Grobmyer SR; Katzen J; Kist KA; Makariou EV; Parris TM; Young CA; Butler R
AJR Am J Roentgenol; 2018 Sep; 211(3):689-700. PubMed ID: 29975115
[TBL] [Abstract][Full Text] [Related]
16. Follow-up results of BI-RADS 3 lesions on magnetic resonance imaging: a retrospective study.
Aslan Ö; Oktay A; Eroğlu F
Diagn Interv Radiol; 2024 May; 30(3):175-182. PubMed ID: 38293846
[TBL] [Abstract][Full Text] [Related]
17. Correlation of ultrasound, cytological, and histological features of 110 benign BI-RADS categories 4C and 5 nonpalpable breast lesions. The Institut Curie's experience.
Farras Roca JA; Tardivon A; Thibault F; Rouzier R; Klijanienko J
Cancer Cytopathol; 2021 Jun; 129(6):479-488. PubMed ID: 33689204
[TBL] [Abstract][Full Text] [Related]
18. Use of BI-RADS 3-probably benign category in the American College of Radiology Imaging Network Digital Mammographic Imaging Screening Trial.
Baum JK; Hanna LG; Acharyya S; Mahoney MC; Conant EF; Bassett LW; Pisano ED
Radiology; 2011 Jul; 260(1):61-7. PubMed ID: 21502382
[TBL] [Abstract][Full Text] [Related]
19. Outcome of initially only magnetic resonance mammography-detected findings with and without correlate at second-look sonography: distribution according to patient history of breast cancer and lesion size.
Linda A; Zuiani C; Londero V; Bazzocchi M
Breast; 2008 Feb; 17(1):51-7. PubMed ID: 17709249
[TBL] [Abstract][Full Text] [Related]
20. Mucocele-like tumors of the breast as cystic lesions: sonographic-pathologic correlation.
Kim SM; Kim HH; Kang DK; Shin HJ; Cho N; Park JM; Cha JH
AJR Am J Roentgenol; 2011 Jun; 196(6):1424-30. PubMed ID: 21606308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
